Pterisolic acid F exhibits potential in pharmaceutical research due to its structural features associated with bioactive triterpenoids. It has drawn interest for its possible anti-inflammatory and antimicrobial properties, making it a candidate for drug development studies. Preliminary evaluations suggest activity against certain pathogenic microbes, which could support its use in designing new antimicrobial agents. Additionally, its presence in fern species known for traditional medicinal use highlights its relevance in ethnopharmacology and natural product validation. Further studies are needed to explore its therapeutic efficacy and mechanism of action.